APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Forecasting Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharma Forecasting Software Market Analysis and Forecast 2026-2032

2 May 2026204 pages

Choose your research edition.

Industry ResearchPharma Forecasting Software Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Forecasting Software Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pharma Forecasting Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Forecasting Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Forecasting Software Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Pharma Forecasting Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharma Forecasting Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharma Forecasting Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharma Forecasting Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharma Forecasting Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharma Forecasting Software include IQVIA, JMP, SAS Institute, Oracle, Inpharmation, J+D Forecasting, ZS Associate, Cognizant and Kinaxis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharma Forecasting Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharma Forecasting Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharma Forecasting Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharma Forecasting Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharma Forecasting Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharma Forecasting Software revenue, projected growth trends, production technology, application and end-user industry.

Pharma Forecasting Software Segment by Company

IQVIA

JMP

SAS Institute

Oracle

Inpharmation

J+D Forecasting

ZS Associate

Cognizant

Kinaxis

Axtria

Symphony Health

Manthan

Model N

Sarjen

Koerber Pharma

WNS

SoftGroup

Nanjing Haiwei Pharmaceutical Technology

Pharma Forecasting Software Segment by Type

Stability Prediction

Formulation and Process Development

Other

Pharma Forecasting Software Segment by Application

Pharmaceutical Companies

Contract Research Organizations (CROs)

Other

Pharma Forecasting Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Forecasting Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Forecasting Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Forecasting Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharma Forecasting Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharma Forecasting Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Forecasting Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharma Forecasting Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stability Prediction Major Player Table 3. Formulation and Process Development Major Player Table 4. Other Major Player Table 5. Global Pharma Forecasting Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical Companies Major Player Table 7. Contract Research Organizations (CROs) Major Player Table 8. Other Major Player Table 9. Pharma Forecasting Software Industry Trends Table 10. Pharma Forecasting Software Industry Drivers Table 11. Pharma Forecasting Software Industry Opportunities and Challenges Table 12. Pharma Forecasting Software Industry Restraints Table 13. Global Pharma Forecasting Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharma Forecasting Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharma Forecasting Software Market Share by Region (2021-2026) Table 16. Global Pharma Forecasting Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharma Forecasting Software Market Share by Region (2027-2032) Table 18. Global Pharma Forecasting Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pharma Forecasting Software Revenue Market Share by Players (2021-2026) Table 20. Global Pharma Forecasting Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharma Forecasting Software Key Players Headquarters & Area Served Table 22. Global Pharma Forecasting Software Players, Product Type & Application Table 23. Global Pharma Forecasting Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharma Forecasting Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pharma Forecasting Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharma Forecasting Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pharma Forecasting Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pharma Forecasting Software Revenue Market Share by Type (2021-2026) Table 30. Global Pharma Forecasting Software Revenue Market Share by Type (2027-2032) Table 31. Global Pharma Forecasting Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharma Forecasting Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pharma Forecasting Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pharma Forecasting Software Revenue Market Share by Application (2021-2026) Table 35. Global Pharma Forecasting Software Revenue Market Share by Application (2027-2032) Table 36. IQVIA Company Information Table 37. IQVIA Business Overview Table 38. IQVIA Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. IQVIA Pharma Forecasting Software Product Portfolio Table 40. IQVIA Recent Development Table 41. JMP Company Information Table 42. JMP Business Overview Table 43. JMP Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. JMP Pharma Forecasting Software Product Portfolio Table 45. JMP Recent Development Table 46. SAS Institute Company Information Table 47. SAS Institute Business Overview Table 48. SAS Institute Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. SAS Institute Pharma Forecasting Software Product Portfolio Table 50. SAS Institute Recent Development Table 51. Oracle Company Information Table 52. Oracle Business Overview Table 53. Oracle Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Oracle Pharma Forecasting Software Product Portfolio Table 55. Oracle Recent Development Table 56. Inpharmation Company Information Table 57. Inpharmation Business Overview Table 58. Inpharmation Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Inpharmation Pharma Forecasting Software Product Portfolio Table 60. Inpharmation Recent Development Table 61. J+D Forecasting Company Information Table 62. J+D Forecasting Business Overview Table 63. J+D Forecasting Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. J+D Forecasting Pharma Forecasting Software Product Portfolio Table 65. J+D Forecasting Recent Development Table 66. ZS Associate Company Information Table 67. ZS Associate Business Overview Table 68. ZS Associate Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ZS Associate Pharma Forecasting Software Product Portfolio Table 70. ZS Associate Recent Development Table 71. Cognizant Company Information Table 72. Cognizant Business Overview Table 73. Cognizant Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Cognizant Pharma Forecasting Software Product Portfolio Table 75. Cognizant Recent Development Table 76. Kinaxis Company Information Table 77. Kinaxis Business Overview Table 78. Kinaxis Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Kinaxis Pharma Forecasting Software Product Portfolio Table 80. Kinaxis Recent Development Table 81. Axtria Company Information Table 82. Axtria Business Overview Table 83. Axtria Pharma Forecasting Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Axtria Pharma Forecasting Software Product Portfolio Table 85. Axtria Recent Development Table 86. Symphony Health Company Information Table 87. Symphony Health Business Overview Table 88. Symphony Health Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Symphony Health Pharma Forecasting Software Product Portfolio Table 90. Symphony Health Recent Development Table 91. Manthan Company Information Table 92. Manthan Business Overview Table 93. Manthan Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Manthan Pharma Forecasting Software Product Portfolio Table 95. Manthan Recent Development Table 96. Model N Company Information Table 97. Model N Business Overview Table 98. Model N Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Model N Pharma Forecasting Software Product Portfolio Table 100. Model N Recent Development Table 101. Sarjen Company Information Table 102. Sarjen Business Overview Table 103. Sarjen Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Sarjen Pharma Forecasting Software Product Portfolio Table 105. Sarjen Recent Development Table 106. Koerber Pharma Company Information Table 107. Koerber Pharma Business Overview Table 108. Koerber Pharma Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Koerber Pharma Pharma Forecasting Software Product Portfolio Table 110. Koerber Pharma Recent Development Table 111. WNS Company Information Table 112. WNS Business Overview Table 113. WNS Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. WNS Pharma Forecasting Software Product Portfolio Table 115. WNS Recent Development Table 116. SoftGroup Company Information Table 117. SoftGroup Business Overview Table 118. SoftGroup Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. SoftGroup Pharma Forecasting Software Product Portfolio Table 120. SoftGroup Recent Development Table 121. Nanjing Haiwei Pharmaceutical Technology Company Information Table 122. Nanjing Haiwei Pharmaceutical Technology Business Overview Table 123. Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Product Portfolio Table 125. Nanjing Haiwei Pharmaceutical Technology Recent Development Table 126. North America Pharma Forecasting Software Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Pharma Forecasting Software Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Pharma Forecasting Software Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Pharma Forecasting Software Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Pharma Forecasting Software Revenue by Country (2021-2026) & (US$ Million) Table 132. North America Pharma Forecasting Software Revenue by Country (US$ Million) & (2027-2032) Table 133. Europe Pharma Forecasting Software Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Pharma Forecasting Software Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Pharma Forecasting Software Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Pharma Forecasting Software Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Pharma Forecasting Software Revenue by Country (2021-2026) & (US$ Million) Table 139. Europe Pharma Forecasting Software Revenue by Country (US$ Million) & (2027-2032) Table 140. China Pharma Forecasting Software Revenue by Type (2021-2026) & (US$ Million) Table 141. China Pharma Forecasting Software Revenue by Type (2027-2032) & (US$ Million) Table 142. China Pharma Forecasting Software Revenue by Application (2021-2026) & (US$ Million) Table 143. China Pharma Forecasting Software Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Pharma Forecasting Software Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Pharma Forecasting Software Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Pharma Forecasting Software Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia Pharma Forecasting Software Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Pharma Forecasting Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Pharma Forecasting Software Revenue by Region (US$ Million) & (2021-2026) Table 150. Asia Pharma Forecasting Software Revenue by Region (US$ Million) & (2027-2032) Table 151. SAMEA Pharma Forecasting Software Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA Pharma Forecasting Software Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA Pharma Forecasting Software Revenue by Application (2021-2026) & (US$ Million) Table 154. SAMEA Pharma Forecasting Software Revenue by Application (2027-2032) & (US$ Million) Table 155. SAMEA Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. SAMEA Pharma Forecasting Software Revenue by Country (2021-2026) & (US$ Million) Table 157. SAMEA Pharma Forecasting Software Revenue by Country (US$ Million) & (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Pharma Forecasting Software Image Figure 2. Global Pharma Forecasting Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Forecasting Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stability Prediction Image Figure 5. Formulation and Process Development Image Figure 6. Other Image Figure 7. Global Pharma Forecasting Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pharma Forecasting Software Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical Companies Image Figure 10. Contract Research Organizations (CROs) Image Figure 11. Other Image Figure 12. Global Pharma Forecasting Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Pharma Forecasting Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharma Forecasting Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pharma Forecasting Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pharma Forecasting Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharma Forecasting Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pharma Forecasting Software Revenue Market Share by Type (2021-2032) Figure 20. Global Pharma Forecasting Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharma Forecasting Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pharma Forecasting Software Revenue Market Share by Application (2021-2032) Figure 23. North America Pharma Forecasting Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pharma Forecasting Software Revenue Share by Type (2021-2032) Figure 25. North America Pharma Forecasting Software Revenue Share by Application (2021-2032) Figure 26. North America Pharma Forecasting Software Revenue Share by Country (2021-2032) Figure 27. United States Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pharma Forecasting Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pharma Forecasting Software Revenue Share by Type (2021-2032) Figure 32. Europe Pharma Forecasting Software Revenue Share by Application (2021-2032) Figure 33. Europe Pharma Forecasting Software Revenue Share by Country (2021-2032) Figure 34. Germany Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pharma Forecasting Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pharma Forecasting Software Revenue Share by Type (2021-2032) Figure 44. China Pharma Forecasting Software Revenue Share by Application (2021-2032) Figure 45. Asia Pharma Forecasting Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pharma Forecasting Software Revenue Share by Type (2021-2032) Figure 47. Asia Pharma Forecasting Software Revenue Share by Application (2021-2032) Figure 48. Asia Pharma Forecasting Software Revenue Share by Region (2021-2032) Figure 49. Japan Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pharma Forecasting Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pharma Forecasting Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Pharma Forecasting Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Pharma Forecasting Software Revenue Share by Country (2021-2032) Figure 59. Brazil Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pharma Forecasting Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Stability Prediction
  • Formulation and Process Development
  • Other
Applications
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Other
Companies covered
  • IQVIA
  • JMP
  • SAS Institute
  • Oracle
  • Inpharmation
  • J+D Forecasting
  • ZS Associate
  • Cognizant
  • Kinaxis
  • Axtria
  • Symphony Health
  • Manthan
  • Model N
  • Sarjen
  • Koerber Pharma
  • WNS
  • SoftGroup
  • Nanjing Haiwei Pharmaceutical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharma Forecasting Software Market by Type
  3. 1.2.1 Global Pharma Forecasting Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stability Prediction
  5. 1.2.3 Formulation and Process Development
  6. 1.2.4 Other
  7. 1.3 Pharma Forecasting Software Market by Application
  8. 1.3.1 Global Pharma Forecasting Software Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Companies
  10. 1.3.3 Contract Research Organizations (CROs)
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pharma Forecasting Software Market Dynamics
  1. 2.1 Pharma Forecasting Software Industry Trends
  2. 2.2 Pharma Forecasting Software Industry Drivers
  3. 2.3 Pharma Forecasting Software Industry Opportunities and Challenges
  4. 2.4 Pharma Forecasting Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharma Forecasting Software Market Perspective (2021-2032)
  2. 3.2 Global Pharma Forecasting Software Growth Trends by Region
  3. 3.2.1 Global Pharma Forecasting Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharma Forecasting Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharma Forecasting Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharma Forecasting Software Revenue by Players
  2. 4.1.1 Global Pharma Forecasting Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharma Forecasting Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharma Forecasting Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharma Forecasting Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharma Forecasting Software Key Players Headquarters & Area Served
  7. 4.4 Global Pharma Forecasting Software Players, Product Type & Application
  8. 4.5 Global Pharma Forecasting Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharma Forecasting Software Market CR5 and HHI
  11. 4.6.3 2025 Pharma Forecasting Software Tier 1, Tier 2, and Tier 3
5 Pharma Forecasting Software Market Size by Type
  1. 5.1 Global Pharma Forecasting Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharma Forecasting Software Revenue by Type (2021-2032)
  3. 5.3 Global Pharma Forecasting Software Revenue Market Share by Type (2021-2032)
6 Pharma Forecasting Software Market Size by Application
  1. 6.1 Global Pharma Forecasting Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharma Forecasting Software Revenue by Application (2021-2032)
  3. 6.3 Global Pharma Forecasting Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IQVIA
  2. 7.1.1 IQVIA Company Information
  3. 7.1.2 IQVIA Business Overview
  4. 7.1.3 IQVIA Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IQVIA Pharma Forecasting Software Product Portfolio
  6. 7.1.5 IQVIA Recent Developments
  7. 7.2 JMP
  8. 7.2.1 JMP Company Information
  9. 7.2.2 JMP Business Overview
  10. 7.2.3 JMP Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 JMP Pharma Forecasting Software Product Portfolio
  12. 7.2.5 JMP Recent Developments
  13. 7.3 SAS Institute
  14. 7.3.1 SAS Institute Company Information
  15. 7.3.2 SAS Institute Business Overview
  16. 7.3.3 SAS Institute Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SAS Institute Pharma Forecasting Software Product Portfolio
  18. 7.3.5 SAS Institute Recent Developments
  19. 7.4 Oracle
  20. 7.4.1 Oracle Company Information
  21. 7.4.2 Oracle Business Overview
  22. 7.4.3 Oracle Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Oracle Pharma Forecasting Software Product Portfolio
  24. 7.4.5 Oracle Recent Developments
  25. 7.5 Inpharmation
  26. 7.5.1 Inpharmation Company Information
  27. 7.5.2 Inpharmation Business Overview
  28. 7.5.3 Inpharmation Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Inpharmation Pharma Forecasting Software Product Portfolio
  30. 7.5.5 Inpharmation Recent Developments
  31. 7.6 J+D Forecasting
  32. 7.6.1 J+D Forecasting Company Information
  33. 7.6.2 J+D Forecasting Business Overview
  34. 7.6.3 J+D Forecasting Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 J+D Forecasting Pharma Forecasting Software Product Portfolio
  36. 7.6.5 J+D Forecasting Recent Developments
  37. 7.7 ZS Associate
  38. 7.7.1 ZS Associate Company Information
  39. 7.7.2 ZS Associate Business Overview
  40. 7.7.3 ZS Associate Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ZS Associate Pharma Forecasting Software Product Portfolio
  42. 7.7.5 ZS Associate Recent Developments
  43. 7.8 Cognizant
  44. 7.8.1 Cognizant Company Information
  45. 7.8.2 Cognizant Business Overview
  46. 7.8.3 Cognizant Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cognizant Pharma Forecasting Software Product Portfolio
  48. 7.8.5 Cognizant Recent Developments
  49. 7.9 Kinaxis
  50. 7.9.1 Kinaxis Company Information
  51. 7.9.2 Kinaxis Business Overview
  52. 7.9.3 Kinaxis Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Kinaxis Pharma Forecasting Software Product Portfolio
  54. 7.9.5 Kinaxis Recent Developments
  55. 7.10 Axtria
  56. 7.10.1 Axtria Company Information
  57. 7.10.2 Axtria Business Overview
  58. 7.10.3 Axtria Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Axtria Pharma Forecasting Software Product Portfolio
  60. 7.10.5 Axtria Recent Developments
  61. 7.11 Symphony Health
  62. 7.11.1 Symphony Health Company Information
  63. 7.11.2 Symphony Health Business Overview
  64. 7.11.3 Symphony Health Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Symphony Health Pharma Forecasting Software Product Portfolio
  66. 7.11.5 Symphony Health Recent Developments
  67. 7.12 Manthan
  68. 7.12.1 Manthan Company Information
  69. 7.12.2 Manthan Business Overview
  70. 7.12.3 Manthan Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Manthan Pharma Forecasting Software Product Portfolio
  72. 7.12.5 Manthan Recent Developments
  73. 7.13 Model N
  74. 7.13.1 Model N Company Information
  75. 7.13.2 Model N Business Overview
  76. 7.13.3 Model N Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Model N Pharma Forecasting Software Product Portfolio
  78. 7.13.5 Model N Recent Developments
  79. 7.14 Sarjen
  80. 7.14.1 Sarjen Company Information
  81. 7.14.2 Sarjen Business Overview
  82. 7.14.3 Sarjen Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sarjen Pharma Forecasting Software Product Portfolio
  84. 7.14.5 Sarjen Recent Developments
  85. 7.15 Koerber Pharma
  86. 7.15.1 Koerber Pharma Company Information
  87. 7.15.2 Koerber Pharma Business Overview
  88. 7.15.3 Koerber Pharma Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Koerber Pharma Pharma Forecasting Software Product Portfolio
  90. 7.15.5 Koerber Pharma Recent Developments
  91. 7.16 WNS
  92. 7.16.1 WNS Company Information
  93. 7.16.2 WNS Business Overview
  94. 7.16.3 WNS Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 WNS Pharma Forecasting Software Product Portfolio
  96. 7.16.5 WNS Recent Developments
  97. 7.17 SoftGroup
  98. 7.17.1 SoftGroup Company Information
  99. 7.17.2 SoftGroup Business Overview
  100. 7.17.3 SoftGroup Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 SoftGroup Pharma Forecasting Software Product Portfolio
  102. 7.17.5 SoftGroup Recent Developments
  103. 7.18 Nanjing Haiwei Pharmaceutical Technology
  104. 7.18.1 Nanjing Haiwei Pharmaceutical Technology Company Information
  105. 7.18.2 Nanjing Haiwei Pharmaceutical Technology Business Overview
  106. 7.18.3 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Product Portfolio
  108. 7.18.5 Nanjing Haiwei Pharmaceutical Technology Recent Developments
8 North America
  1. 8.1 North America Pharma Forecasting Software Revenue (2021-2032)
  2. 8.2 North America Pharma Forecasting Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharma Forecasting Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharma Forecasting Software Revenue by Type (2027-2032)
  5. 8.3 North America Pharma Forecasting Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharma Forecasting Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharma Forecasting Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharma Forecasting Software Revenue by Application (2027-2032)
  9. 8.5 North America Pharma Forecasting Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharma Forecasting Software Revenue by Country
  11. 8.6.1 North America Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharma Forecasting Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharma Forecasting Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharma Forecasting Software Revenue (2021-2032)
  2. 9.2 Europe Pharma Forecasting Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharma Forecasting Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharma Forecasting Software Revenue by Type (2027-2032)
  5. 9.3 Europe Pharma Forecasting Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharma Forecasting Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharma Forecasting Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharma Forecasting Software Revenue by Application (2027-2032)
  9. 9.5 Europe Pharma Forecasting Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharma Forecasting Software Revenue by Country
  11. 9.6.1 Europe Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharma Forecasting Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharma Forecasting Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharma Forecasting Software Revenue (2021-2032)
  2. 10.2 China Pharma Forecasting Software Revenue by Type (2021-2032)
  3. 10.2.1 China Pharma Forecasting Software Revenue by Type (2021-2026)
  4. 10.2.2 China Pharma Forecasting Software Revenue by Type (2027-2032)
  5. 10.3 China Pharma Forecasting Software Revenue Share by Type (2021-2032)
  6. 10.4 China Pharma Forecasting Software Revenue by Application (2021-2032)
  7. 10.4.1 China Pharma Forecasting Software Revenue by Application (2021-2026)
  8. 10.4.2 China Pharma Forecasting Software Revenue by Application (2027-2032)
  9. 10.5 China Pharma Forecasting Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharma Forecasting Software Revenue (2021-2032)
  2. 11.2 Asia Pharma Forecasting Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharma Forecasting Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharma Forecasting Software Revenue by Type (2027-2032)
  5. 11.3 Asia Pharma Forecasting Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharma Forecasting Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharma Forecasting Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharma Forecasting Software Revenue by Application (2027-2032)
  9. 11.5 Asia Pharma Forecasting Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharma Forecasting Software Revenue by Country
  11. 11.6.1 Asia Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharma Forecasting Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharma Forecasting Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharma Forecasting Software Revenue (2021-2032)
  2. 12.2 SAMEA Pharma Forecasting Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharma Forecasting Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharma Forecasting Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharma Forecasting Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharma Forecasting Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharma Forecasting Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharma Forecasting Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharma Forecasting Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharma Forecasting Software Revenue by Country
  11. 12.6.1 SAMEA Pharma Forecasting Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharma Forecasting Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharma Forecasting Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst